Annual report pursuant to Section 13 and 15(d)

Summary Significant Accounting Policies Parentheticals (Details)

v2.4.0.8
Summary Significant Accounting Policies Parentheticals (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Summary Significant Accounting Policies Parentheticals    
Amortization of deferred financing costs related to convertible debt $ 30,122 $ 13,722
Research Expenses - Salaries and equipment related expenses 41,000 137,000
Clinical Studies expenses - fees, charges and related expenses 977,000 540,000
Compensation expenses recorded $ 472,975 $ 48,489